AI in medical communications

Integration of AI in Medical Communications: A Roadmap

AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
man-accessing-data

New Open Data Sharing Policies: WHO and NIH Take Big Steps to Improve Public Health

Making research and data reproducible is vital to improving public health and reinstating trust in...
a-man-questioning-medical-device-regulatory-options

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Understanding the requirements for your medical device is vital in today’s market. But are these...
Medical device regulation and how the safety, performance, and RMS align

Simple Considerations before Determining S&P Objectives for Medical Devices

With all the things to consider with Medical Device Regulations, it's important to identify the...
Racial and Ethnic Diversity in Pharma and Clinical Trials

Racial and Ethnic Diversity in Pharma and Clinical Trials

CACTUS strongly supports inclusion and diversity and is working hard to raise awareness about this...
DE&I Infographic #1

The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry

To learn how much businesses can gain from more diverse and inclusive workplaces and why...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...

Learn more ABOUT our company.